Head-to-head · WeighScore
Obu Health vs yourEra
By GLP-1 ScorecardUpdated
Score comparison
yourEra has the higher recorded score — 83.8/100 to 59.9/100.
yourEra grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Compounded semaglutide and tirzepatide injections advertised at $89/$129 monthly for new patients, with a named medical practice and three possible pharmacies; confirm the continuing price because homepage and terms differ.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Obu Health | yourEra |
|---|---|---|
| WeighScore | 59.9/100 | 83.8/100 |
| Grade | C | B |
| Site position | #378 | #7 |
| Semaglutide | $190/mo (starting dose, plus a separate fee, compounded) | $89/mo (new-patient offer; confirm refill terms) |
| Tirzepatide | $239/mo (starting dose, plus a separate fee, compounded) | $129/mo (new-patient offer; confirm refill terms) |
| Coverage | Coverage not published | 50-state clinician network; treatment availability varies by state |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #378 · C
Strengths
- LegitScript-certified with publicly displayed ID (44206977)
- Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
- Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
- Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
- 24-hour US board-certified physician response window
What to consider
- Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
- No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
- Medical director not named publicly
- No published consultation fee disclosure — unclear whether physician visit is included in medication price
- All sales final per FAQ ('Federal and State law do not allow medication returns')
Site position #7 · B
Strengths
- Public new-patient month-to-month prices; advertised same price across doses while active
- Evaluation, medication, injection supplies, dose management and shipping advertised together
- Terms name Thryv Telehealth by Lavin, P.C. and three potential dispensing pharmacies
- Free requested live visit; policy promises full refund if canceled before dispatch
What to consider
- Compounded formulations are not FDA-approved branded products
- Homepage price-continuation promise and terms allowing future refill price changes need reconciliation
- Optimum coaching, nutrition, at-home labs and wearables are coming soon, with no confirmed price or launch date
- Assessment usually asynchronous; prescription issuance triggers billing, and treatment availability varies by state
Featured provider
yourEra
yourEra scores 83.8/100 (B). Compounded semaglutide and tirzepatide injections advertised at $89/$129 monthly for new patients, with a named medical practice and three possible pharmacies; confirm the continuing price because homepage and terms differ.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.